<DOC>
	<DOCNO>NCT01517191</DOCNO>
	<brief_summary>This surveillance study include consent adult hospitalize influenza ( case ) SOS network hospital well influenza negative patient ( control ) , assess vaccine effectiveness group . Both group follow throughout hospitalization 30 day post discharge monitor severity illness outcomes follow illness .</brief_summary>
	<brief_title>Sentinel Surveillance Influenza Requiring Hospital Admission Canadian Adults</brief_title>
	<detailed_description>The Public Health Agency Canada/Canadian Institutes Health Research Influenza Research Network ( PCIRN ) collaborative research network bring together 100 investigator 40 institution evaluate factor relevant introduction pandemic influenza vaccine Canada . The Serious Outcomes Surveillance ( SOS ) Network within PCIRN establish 2009 plan evaluation influenza vaccine safety effectiveness . Vaccine effectiveness study critical assess vaccine effectiveness real world condition assess vaccine effectiveness prevention severe outcomes . Establishing methodology infrastructure real-time field assessment vaccine effectiveness crucial inform policy recommendation optimal use resource , include vaccine . This study include consent adult patient hospitalize one SOS Network hospital influenza season test positive influenza ( case ) . In addition two influenza negative control match case measure difference vaccine effectiveness . Specific study aim : 1 . To determine effectiveness trivalent influenza vaccination ( TIV general , GSK TIV particular ) prevent influenza-associated hospitalization adult ≥ 65 year , 2 . To determine effectiveness influenza vaccination prevent influenza-associated death adult ≥ 65 year 3 . To determine effectiveness influenza vaccination prevent influenza-associated hospitalization death adult &lt; 65 year 4 . To characterize burden disease , clinical outcome , resource utilization associate influenza A influenza B lineages 5 . To examine clinical immunologic factor impact severity disease influenza vaccine effectiveness adult</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<criteria>Adult patient ≥ 16 year age admit participate SOS Network hospital follow admit diagnosis eligible screen within 5 day admission : communityacquired pneumonia acute exacerbation chronic obstructive pulmonary disease ( AECOPD ) asthma unexplained sepsis Any respiratory infection diagnosis Or respiratory influenzalike symptom ) ( eg dyspnea , cough , sore throat , myalgia , arthralgia , fever ) One day per week , begin local laboratory report influenza positivity rate ≥ 5 % test submit , patient admit follow also screen : Acute coronary syndrome ( eg myocardial infarction , unstable angina ) triage temperature ≥37.5°C Any cardiac diagnosis ( eg atrial fibrillation , arrhythmia , myocarditis ) triage temperature ≥ 37.5°C Stroke triage temperature ≥37.5°C Patients whose reason admission clearly unrelated presence influenza ( example , patient admit due trauma , elective surgery , patient alternative diagnosis clearly cardiac , respiratory , neurologic , e.g . cellulitis , intraabdominal process , gastrointestinal bleeding ) Patients test positive ( case ) immunization status ascertain excluded vaccine effectiveness analysis component study , however , still enrol include burden influenza Patients test negative influenza ( control ) immunization status ascertain ( verbal self report source ) eligible enrolment No child care enrol study</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Influenza</keyword>
	<keyword>Respiratory Infection</keyword>
</DOC>